“…2 cIMT is widely used as a surrogate marker for atherosclerotic disease based on inflammation. 4 In this context, we demonstrated that cIMT measurement is higher in patients with psoriasis compared with the control subjects. 5 So, it may be considered that increased inflammation of psoriasis contributes to atherogenesis and coronary artery disease.…”